The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 67 | 4.2x | 20.1x | Near average | |
Growth | 56 | -11.9% | 5.6% | Near average | |
Quality | 56 | -1.9% | 7.6% | Near average | |
Safety | 27 | 1.3x | 0.4x | Below average | |
Capital Return | 33 | — | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
HUTCHMED (China) Limited is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy HUTCHMED (China) Limited shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
HUTCHMED stock witnessed a notable decline in expectations over the past week, as the average price target dropped by 22.29% to reach 13.6 dollars after being stable at 17.5 dollars. Remarkably, there is currently a complete alignment between the high and low targets (13.6 dollars) among 13 analysts, indicating a sudden technical consensus or a comprehensive collective reassessment of the company's future risks.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.